[Study of the effect of converting enzyme inhibitors on microalbuminuria in diabetics].
The authors report the results of a randomised trial using a converting enzyme inhibitor in 40 microalbuminuric diabetic subjects during 18 months. In the treated group, we observed a reduction of albuminuria from 57.4 mg/24 hours to 35.4 mg/24 hours at the end of the follow up, in contrast with a non significant progression in the group who didn't receive this medication. No significant modification in the clinical and biological parameters was observed during the follow up.
Ben Rhaiem
B
B
Service d'Endocrinologie, Diabétologie-Hôpital La Rabta, Tunis.
Ben Brahim
S
S
Fekih
M
M
Ftouhi
B
B
Harzallah
F
F
Kanoun
F
F
Mekaouar
A
A
M'bazaa
A
A
Ben khalifa
F
F
D000328:Adult; D000368:Aged; D000419:Albuminuria / Q000188:drug therapy* / Q000209:etiology; D048909:Diabetes Complications; D004791:Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D004791:Enzyme Inhibitors